USP 1111

Microbiological Examination of Non sterile products 

Hassle-free testing experience

Need to get a product tested? No worries! To and fro logistics are on us; we collect your products, test them and, deliver them back to you.

Summary

USP 1111 is the microbiological acceptance criteria for non-sterile pharmaceutical preparations and products. It defines the limits for microbial contamination, including Total Aerobic Microbial Count (TAMC) and Total Combined Yeasts and Molds Count (TYMC), helping manufacturers control bioburden and protect product quality, therapeutic performance, and patient safety.

Related tests for you

Microbial Enumeration Test
Antimicrobial Effectiveness Test
Ensuring Safety in Non-Sterile Medical Products
Enumeration of Yeast and Mould present in Cosmetics
Measurement of Mesophilic Aerobic Bacteria in a given sample

What is USP 1111?

USP 1111 provides microbiological acceptance criteria for non-sterile pharmaceutical products. It helps manufacturers assess whether microbial levels in products remain within acceptable limits to support product quality, safety, and efficacy. The criteria are based primarily on Total Aerobic Microbial Count (TAMC) and Total Yeasts and Molds Count (TYMC). Microbial enumeration is performed using USP 61, while USP 62 is used to detect specified microorganisms.

The values for acceptance criteria for TAMC and TYMC are provided in Table 1 and Table 2, respectively. Acceptable count values are interpreted as –

10 1 cfu: maximum acceptable count = 20

10 2 cfu: maximum acceptable count = 200

10 3  cfu: maximum acceptable count = 2000; and so forth.

Compliance with these given microbial limits helps to maintain product safety, stability, and efficacy.

Quick understanding of the test

USP 1111 – Microbiological Examination of Non sterile products

The USP 1111 outlines the microbiological examination and acceptance criteria for nonsterile pharmaceutical products.

Do you have a product that needs testing?

Get a quote from our experts today!

USP 1111 – Acceptance Criteria for Non-Sterile Pharmaceutical Products

Table 1 : Acceptance Criteria for Microbiological Quality of Nonsterile Dosage Forms

Table 2. Acceptance Criteria for Microbiological Quality of Nonsterile Substances

Importance of USP 1111

Safety Assurance

By setting specific microbial limits for nonsterile pharmaceuticals, USP 1111 helps ensure that these products are safe for consumer use. The presence of excessive microorganisms can compromise product safety and effectiveness, potentially leading to adverse health effects.

Quality Control

By setting specific acceptance criteria, USP 1111 helps manufacturers maintain consistent quality in their products. It ensures that the microbial bioburden is kept at a low level, which is essential for the stability and efficacy of the product.

Regulatory Compliance

Adhering to USP 1111 is mandatory for pharmaceutical manufacturers to meet regulatory requirements. Compliance helps avoid legal issues and product recalls, which can be costly and damage a company’s reputation.

Risk Mitigation

By implementing the standards set forth in USP 1111, manufacturers can significantly reduce the risk of contamination. This proactive approach is beneficial for preventing complications associated with microbial contamination, such as infections or product inefficacy.

Regulatory relevance of USP 1111

USP 1111 establishes a framework for assessing the microbiological quality of on-sterile pharmaceutical products and ensuring compliance with acceptable microbial limits

  • It provides acceptance criteria to evaluate whether microbial levels in products remain within defined safety and quality thresholds
  • It supports consistent microbiological quality control across different stages of pharmaceutical manufacturing
  • It works in combination with USP 61 and USP 61 to provide a validated approach to microbial testing
  • It helps demonstrate compliance with established microbiological quality expectations for regulatory and quality assurance purposes

Conclusion

At MIS,  we offer an extensive portfolio of USP testing services globally. Our testing capabilities include USP 61, USP 62, and USP 60. With our extensive expertise in the field of microbiology, we are committed to delivering accurate and reliable results for each test conducted. 

We specialize in offering customized testing services tailored to specific needs of clients. Our microbiology experts meticulously design protocols that align with your requirements and USP guidelines.

Need any assistance with USP testing services, contact our experts here.

Frequently Asked Questions on USP 1111 - Microbiological Examination

DR. Martinoz Scholtz

MIS Labs

1. What is USP 1111?

USP 1111 outlines the acceptance criteria for nonsterile pharmaceutical products through microbial enumeration tests.  

2. What types of products are evaluated under the criteria provided by USP 1111?

USP 1111 test is applicable for non-sterile products such as topical products, inhalation products, parenteral products, eye and ear preparations, etc.

3. Why is the USP 1111 test important in pharmaceutical manufacturing?

This  test is crucial in pharmaceutical manufacturing as it ensures the microbiological safety and quality of non-sterile products, protecting patient health and maintaining compliance with regulatory standards.

4. Which regulatory bodies recognize USP 1111 standards?

Regulatory bodies like the FDA, EMA, and WHO recognize USP 1111 standards for ensuring pharmaceutical product safety and quality.

Meet the best of the blend of
R&D, Efficacy Testing,
Innovation and Passionate
Experts at MIS.

Send us your sample and experience High quality Swiss standards, Industry leading turnaround times, and affordable prices.

    Explore More